Identification of Molds Using MALDI-TOF: Lessons Learned from Feasibility for Validation and Implementation

[Article Title]

Pharma manufacturers frequently face mold contamination. Marie-Laurence Baille from MSD (Merck in US, Canada) shares insights on fungal ID using MALDI-TOF, database limitations, and DNA sequencing challenges. Duncan Barlow from Charles River adds ITS2 vs. D2 comparisons and how Accugenix® improves fungal ID accuracy with frequent library updates. Enhance your fungal identification process with these new learnings.

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.